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ABSTRACT 
 
A biomimetic minimalist model membrane was used to study the mechanism and kinetics of 
cell-free in vitro HIV-1 Gag budding from a giant unilamellar vesicle (GUV).  Real time 
interaction of Gag, RNA and lipid leading to the formation of mini-vesicles was measured using 
confocal microscopy.   Gag forms resolution limited punctae on the GUV lipid membrane. 
Introduction of the Gag and urea to a GUV solution containing RNA led to the budding of mini-
vesicles on the inside surface of the GUV.  The GUV diameter showed a linear decrease in time 
due to bud formation. Both bud formation and decrease in GUV size were proportional to Gag 
concentration.  In the absence of RNA, addition of urea to GUVs incubated with Gag also 
resulted in subvesicle formation but exterior to the surface.   These observations suggest the 
possibility that clustering of GAG proteins leads to membrane invagination even in the absence 
of host cell proteins. The method presented here is promising, and allows for systematic study of 
the dynamics of assembly of immature HIV and help classify the hierarchy of factors that impact 
the Gag protein initiated assembly of retroviruses such as HIV.   
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Introduction 
 
A remarkable feature of retroviruses such as the human immunodeficiency virus (HIV-I) 
is that, one structural polyprotein coded by the viral genome, Gag, together with the viral RNA 
lead to the  spontaneous assembly of virus like particles in mammalian cells [1-6].  HIV-I Gag is 
a 55kD multi domain peptide with 4 primary structural domains which from the N to C terminus 
are: matrix (MA, P17), capsid (CA, P24), nucleo capsid (NC, P7) and p6, In mature particles the 
CA domain forms the shell around the virus, the NC domain consolidates and protects the RNA 
genome at the viral core.   In the prevailing hypothesis  [1,3,2], the multistep HIV-I assembly is 
initiated by viral RNA binding to the NC domain of Gag. The origin of the binding is thought to 
be negatively charged RNA attracted to positively charged MA and NC domains [7]. This 
complex is transported to the host plasma membrane [8] along with  cellular proteins, such as the 
endosomal sorting complex required for transport (ESCRT) [9-11].  The Gag MA domain binds 
to the cytoplasmic plasma membrane through electrostatic forces resulting from a patch of basic 
residues [12] and insertion of hydrophobic covalently bound myristoyl fatty acid chain into the 
bilayer  [13]. The binding is facilitated by negatively charged (anionic) PI(4,5)P2 lipids.  The 
lipid and RNA binding causes Gag to unfold into a rod, which leads to  tight hexagonal packing 
assembly [14,15,7,16,17].  Electron microscopy studies [18,1,16,14,19] show that Gag 
aggregates on the inner cytoplasmic leaflet of the plasma membrane lead to budding into the 
extracellular space and to the release of immature virus like particles.  In these immature freshly 
budded spherical particles, the Gag proteins are radially located.  Following the budding process, 
action of the viral protease leads to the cone shaped capsid of mature HIV-1. 
Gag’s central role in HIV replication and infectivity has been well established using in 
vivo and in vitro studies [1,6,3], but many questions remain open, particularly regarding the 
kinetics, reaction pathways and necessary cellular components involved. For example, mutant 
Gag, in which Gag-lipid binding, Gag-nucleic acid binding and Gag-Gag dimerization were 
independently modified in T-cells, showed that not all three interactions are needed but at least 
two were necessary for the formation of virus like particles [20]. This finding opens new 
questions on the combined role of Gag, nucleic acids and lipids in HIV formation. 
A simple cell-free in vitro system would be highly beneficial in ascertaining the clear 
roles of the different Gag domains and their rates of interaction with lipids and RNA. This is 
mainly due to the fact that in in vivo studies, it is difficult to clearly interpret the key roles of 
RNA and lipids as Gag comes into contact with a number of cellular components that might 
rescue or alter the kinetics.  For example, budding of virus like particles in HeLa cells has been 
investigated using Total Internal Reflection Fluorescence Microscopy (TIRFM) [21,22] and 
Atomic Force Microscopy (AFM) [23].  However, the cellular environment is difficult to control 
and it is frequently unclear whether the observed phenomena result from input Gag, RNA or due 
to the complex interaction of cellular factors, as numerous cellular proteins might interact with 
Gag during assembly [24].  Similarly many cell free systems, such as template directed assembly 
on gold nanoparticles [25,26], and wheat germs or reticulocyte lysates, which have been used to 
study retrovirus assembly, while useful, have the same disadvantages [27-30].  
To investigate whether GAG induces membrane invaginations in the absence of RNA 
and cellular proteins and to analyze vesicle formation in a controlled manner we employed a 
minimal giant unilammellar vesicle (GUV) system.  The mechanics and kinetics of Gag 
interaction with a lipid bilayer were monitored using confocal microscopy. In the absence of 
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RNA and cellular proteins, Gag molecules aggregate and form mini-buds only in the presence of 
urea in solution, i.e., the sole interaction of Gag with membrane is not sufficient for formation of 
mini-vesicles. Further the addition of Gag along with yeast tRNA leads to multimerization of 
Gag and formation of Gag punctae, and budding of mini-vesicles followed by rapid 
disintegration of GUV into minivesicles, in the absence of any host cell proteins but with urea 
present. The system promises to be a very useful platform to study many of the critical factors, 
such as the role of the different Gag structural domains, lipids and RNA and to identify ligands 
and cofactors that effect and impact Gag induced assembly of HIV.  Controls using 
unmyristoylated Gag P55, the capsid domain Gag P24, and urea, were done. We found that 
complete Gag P55 along with urea is necessary to observe budding in the GUVs.  The essential 
role of urea in vesicle formation in the cell-free system suggests that conformational changes of 
the Gag protein mediated by other cellular factors maybe pivotal for virion egress.   
 
Materials & Methods 
 
Materials 
            The lipids DPhPC (1,2-diphytanoyl-sn-glycero-3-phosphocholine) and POPC (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), cholesterol, and brain PI(4,5)P2 (L-α-
phosphatidylinositol-4,5-bisphosphate) were from Avanti Polar Lipids (Alabaster, AL). For 
labeling membranes the fluorescent stain DilC18 (1,1'-dioctadecyl-3,3,3',3'-tetramethylin 
dodicarbocyanine perchlorate) was from Invitrogen (Carlsbad, California).  DyLight 488 NHS-
Ester protein labeling kit and unmyristoylated Gag P55 was purchased from Thermo Scientific 
(Rockford, IL). Urea was from Fisher Scientific.  The myristoylated Gag P55 reagent at 1 mg/ml 
concentration in PBS, was obtained through the NIH AIDS Reagent Program, Division of AIDS, 
NIAID, NIH: HIV-1IIIB pr55 Gag. The capsid domain HIV-1 p24 IIIB P24 at 1 mg/ml 
concentration  in 20mM Na-Ac, 0.05M NaCl, pH 6.5 was also obtained through the NIH AIDS 
Reagent Program. 
 .  
Preparation of giant lipid vesicles: 
        Giant vesicles were prepared by using the gentle hydration method. In short, a lipid mixture 
of DPhPC:POPC:PI(4,5)P2:Cholesterol  (molar ratio 11:4:1:4)  was used and  doped with 0.1 
mol% of the lipid stain DilC18.  The mixture was dissolved in methanol/chloroform [2:1 (v/v)]. 
Lipids in the solvent were transferred to a clean roughed Teflon plate, which was placed in a 
beaker and sealed with aluminum foil. The solvent was then removed by placing the beaker in 
vacuum for 6 h. After that, argon gas saturated with water vapor at a temperature of 45 
o
C (above 
the transition temperature of the lipid) was blown over the Teflon plate for 20 min and 10 ml of 
200 mM sucrose in distilled water was added to the beaker. The sucrose was necessary for 
weight loading the GUV to keep it stable during confocal microscopy. The hydration process 
was allowed to occur overnight. Following hydration, “clouds” of vesicles were observed. The 
giant vesicles were harvested by aspirating with a Pasteur pipette and examined directly under a 
fluorescence microscope. These giant vesicles were stable for one week when stored at 4 
o
C. 
 
Labeling of Gag with DyLight 488: 
        Ten μl of borate buffer (0.67 M) was added to one 2.5 μl DyLight 488 vial. The solution 
was mixed with 25 μl of 1mg/ml myristoylated Gag P55 and vortexed gently for 1 min. The 
mixture was incubated in the dark for 1 h at room temperature.  Excess DyLight was removed 
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from the labeled Gag using centrifugation through a size exclusion column as suggested by the 
supplier.  The same labelling procedure was used for unmyristoylated Gag P55 and the capsid 
domain Gag P24. Freshly labeled Gag was used in all the reported experiments. For experiments 
where myristoylated Gag with urea was added to the GUV solution, the 0.5 mg/ml labeled Gag 
was mixed with an equal volume of 12 M urea in PBS buffer and stored for 2 h.  This mixture 
was then diluted by a factor of 5 with PBS buffer prior to use resulting in a 0.05 mg/ml 
myristoylated Gag P55 in a 1.2 M urea solution. 
 
Confocal Microscopy: 
         Confocal microscopy was performed using a Leica SP5 microscope fitted with a 40X water 
immersion objective (N.A=1.1). Two excitation light sources with wavelengths of 488 nm and 
633 nm were used.  Collection light wavelengths filters at 450-550 nm in the green and 600-700 
nm in the red were used in the results reported.  The imaging plane was maintained at the 
equatorial plane of the vesicles. GUVs were added to an imaging cell containing two ml of 200 
mM glucose in distilled water. The glucose balances the osmotic pressure of 200 mM sucrose 
inside the GUV.  The heavier sucrose keeps the vesicle relatively immobile during imaging and 
the introduction of reactants.  It was independently confirmed that the sucrose and glucose do not 
participate in any of the reactions.  
 
Controls: 
Gag Capsid domain:  The effect of Gag P24, the capsid domain of Gag P55, on GUVs was 
studied.  Here Gag P24 labelled with DyLight 488 was added to the GUV containing test cell. 
The GUVs were observed in the confocal microscope. The final concentration of Gag P24 in the 
test cell was 180 nM. Even at this concentration (10x of myristoylated Gag P55 used)  no 
punctae on the GUVs were observed.  The GUVs remained unchanged and no budding 
phenomena was detected. Thus the Gag P24 was observed to not bind to the lipid membrane of 
the GUV.  
 
Unmyristoylated Gag P55 in urea:  The necessity of N terminal myristoylation of Gag P55 for 
binding to lipid membranes and the formation of virus like particles has been well studied [31-
33].  Unmyristoylated Gag is thus an excellent control to study Gag mediated vesicle budding in 
GUVs. The experiment reported below with myristoylated Gag P55 in urea was repeated with 
unmyristoylated Gag P55 and found to have no effects on GUVs.  Here 0.05 mg/ml 
unmyristoylated Gag P55 in urea solution was added to the GUV test cell in steps till the 
concentration reached 28 nM Gag in 42 mM urea. The GUVs remained unaffected when 
observed under the confocal microscope. Even though the concentration of unmyristoylated Gag 
and urea reached nearly three times that of the case of myristoylated Gag no budding or decrease 
of the GUV surface area was observed. 
 
Urea: The effect of only urea on the GUVs was also studied.  0.6 M urea in PBS was added to 
the GUV containing test cell in 10 l steps till the concentration reached 15 mM (the same as 
used with myristoylated Gag P55). Again the GUVs remained unaltered and no vesicle budding 
on the GUV surface or decrease in the GUV diameter with time was observed.  No change in 
GUVs were observed even when the urea concentration was increased to 20 mM.  The same was 
repeated for yeast RNA containing GUVs. Again no change due to the addition of urea was 
observed.  
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Results & Discussion 
 
Unilamellar and multilamellar GUVs labeled with DilC18 (red fluorescent lipid stain) 
were prepared as described in Material and Methods.  HIV Gag p55 was labeled with DyLight 
488 (green fluorescence). Confocal images were collected at excitation laser light (488 nm and 
633nm) and with emission wavelength filters (450-550 nm (green) and 600-700 nm (red)). 
 
Gag interaction with GUV: 
We investigated the binding of myristoylated Gag P55 to the GUV lipid membrane.  It 
has been shown [34,35] that the MA domain of Gag has a binding site for PI(4,5) P2 anionic 
lipid, and GAG specifically binds PI(4,5)P2 containing GUVs [10].  Gag binds lipids through 
electrostatic and hydrophobic interactions. Basic residues of the MA domain, which 
electrostatically bind to anionic lipids and the N terminal hydrophobic myristate group is 
conjectured to insert into bilayers [31-33].  To verify that GAG specifically binds GUV lipids, 
we incubated DyLight 488 labeled myristoylated Gag (50nM) with DilC18 labeled GUV solution. 
After an hour of incubation the GUVs were inspected with a confocal microscope.  As observed 
in Fig. 1, midplane GUV images show the presence of bright green punctae on the bilayer 
membrane.  No budding or local distortions of the GUV profile due to the presence of Gag could 
be observed. Gag punctae were relatively uniformly sized with a diameter of 900 nm, and 
punctae sizes were similar to that observed by Carlson and Hurley [10].   The observed sizes 
were not true sizes due to the resolution limit and image smearing from thermal and mechanical 
motion of the vesicle surface. This is confirmed from the fact that the observed GUV membrane 
thickness nominally of 5 nm was about 600-700 nm in the image.  Note that the confocal 
microscope resolution limit is around 500 nm.  The lack of punctae larger than 900 nm indicates 
that there was an optimum preferred size for Gag puncta on the lipid membrane. We believe that 
the Gag molecules aggregate after their insertion into the membrane. An alternate hypothesis is 
the insertion of fully formed Gag particulates into the GUV membrane. Insertion of whole Gag 
clusters into the GUV membrane is not as probable due to size. The uniformity of punctae 
observed and absence of larger aggregates on the lipid membranes points to their probable 
assembly in the bilayer. This maximum size of the Gag puncta could be the result of a 
competition between the spontaneous curvature of Gag proteins, the membrane bending rigidity 
and tension, and unfavorable energetic costs at the domain boundary.  As a control, the effect of 
Gag P24, the capsid domain of Gag P55, on GUVs was studied.  As above the Gag P24 labelled 
with DyLight 488 was added to the GUV containing test cell. Even at a 180 nM final 
concentration of Gag P24 in the test cell no punctae on the GUVs were observed.   
 
 
Dynamics of Gag puncta: 
When two puncta approached each other, they appeared to have a repulsive force 
between them.  The force is probably of elastic origin resulting from the membrane deformation 
induced by bound Gag. This repulsion leads to the relatively uniform size distribution of the Gag 
punctae observed.   Such elastic repulsive forces were observed in dimpled lipid domains on 
GUV [36], and result from competition between membrane bending stiffness and boundary line 
tension. Gag puncta were found to undergo Brownian motion on the vesicle surface.  The 
translational diffusion of a particle due to Brownian motion on a planar fluid surface such as a 
lipid bilayer membrane is given by  <r
2
> = 4 Dt, where r is the distance traveled in time interval t 
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and D is the diffusion coefficient [37].  Since the distance travelled at in our  experiments was 
much smaller than the GUV radius, we ignored the curvature of space when measuring D.  We 
calculated the mean squared displacement of Gag puncta <r
2
> along the vesicle surface as 
observed in confocal images for each time interval t=0.75 s.  The diffusion coefficient D 
calculated from averaging r
2
 for five puncta over 80 intervals was found to be 0.17±0.02 m2/ 
sec. The error was the standard error of the mean.  Embedded proteins on an artificial two-
dimensional membrane have been observed to undergo Brownian motion [38].  The measured 
diffusion coefficient D, with the time and distance resolution as observed here, for single 
proteins varied from 4-0.58 m2/ sec in artificially constituted lipid membranes [38]. The 
observed D for Gag puncta is 6-24 times less than that for monomers on bilayer membranes.  It 
is known that in the case of two-dimensional lipid like fluids, the diffusion coefficient D is 
inversely related to the particle diameter [37].  The observed small value of the diffusion 
coefficient in Gag is probably due to its multimerization on the lipid membrane.  A decrease by a 
factor of 6-14 in the diffusion constant is consistent with a multimer size that is between 36-576 
times that of the monomer. Thus the value of D obtained is consistent with multimer formation 
in the presence of lipids as observed in NMR [39], circular dichroism (CD) [40], electron 
microscopy [41,42], small angle neutron scattering (SANS) [40] and  neutron reflectivity [7].   
 
RNA interaction with GUV: 
Next we investigated the interaction of RNA on the GUV lipid membrane.  GUVs of 
diameter around 30 m were imaged in a confocal microscope using a two ml test cell. The 
equatorial plane of the GUV appeared as uniform circles with a resolution limited thickness of 
around 500 nm (Fig. 2a). Then 20 l of 20 mg/ml yeast tRNA were added to the GUV solution 
resulting in a 5 M RNA concentration. The vesicle was observed for 10 mins.  A typical image 
is shown in Fig. 2b. No visible changes in the shape of the GUV were observed due to the 
presence of RNA.  Some inhomogeneities in the fluorescence intensity along the vesicle surface 
were noted indicating that RNA-lipid interactions led to lipid density changes.  The dense 
regions of around 1 m in size were relatively immobile in comparison to the Gag puncta 
observed in Fig. 1.  Their diffusion rate on the GUV surface was much lower with a value of 
0.10±0.02 m2/ sec, tracking four samples for 40 time intervals.  No change in the GUV 
diameter with time was observed. The lipid density inhomogeneities might be due to the 
presence of lipid raft like micro domain platforms, which form the substrate for future vesicle 
budding. Such micro-domain formation has been hypothesized as a precursor to budding [43].   
Further investigations are necessary to confirm the properties and origin of these 
inhomogeneities.   
 
 
Gag and RNA interaction with GUV: 
Next the role of Gag in vesicle budding with RNA containing GUV was studied using the 
same two ml sample cell.  A solution with 0.05 mg/ml Gag in 1.2 M urea was added to the GUV 
test cell in 5 l steps. After the addition of 25 l corresponding to a 10 nM Gag concentration 
(with 15 mM urea) solution, modifications of the GUV surface could be observed.  A typical 
modification is shown in Fig. 2c.  In addition to the inhomogeneities in fluorescence observed 
with RNA in Fig. 2b, buds of diameter 2.5±0.5 m appeared on the inside surface of the GUV. 
One such bud is indicated with an arrow in Fig. 2c.  The appearance of these buds corresponded 
to a decrease in the GUV diameter. The change in GUV diameter as a function of time is shown 
7 
 
in Fig. 4.   Over 240 s the rate of change of the diameter is linear. This will be discussed in more 
detail in the section below.   Control experiments with just RNA and the same volume of 1.2 M 
urea introduced into the GUV solution led to no changes in the GUVs. Additional control 
experiments using a myristoylated Gag P55 solution without urea were done and found to have 
no effect on the RNA containing GUVs.  
 
When the Gag concentration in the GUV solution was increased to 20 nM, a rapid change 
of the GUV profile was observed as shown in Fig. 3a-d.  As illustrated in the figure, additional 
buds appeared on the inside surface. The resolution limited average diameter of the buds was 2.2 
±0.5 m.  Here the error corresponds to the instrument resolution as typified by the thickness of 
the vesicle bilayer membrane in the image.  These buds underwent Brownian motion on the 
GUV surface, with a diffusion coefficient D of 0.11±0.02 m2/s, for four samples tracked for 61 
time intervals.  The lower diffusion rates observed for the buds show that they are distinctly 
different in structure and membrane site location from the Gag puncta observed in Fig. 1.   The 
buds tended to aggregate in one location on the GUV surface. The location of the aggregate is 
indicated with an arrow in Fig. 3c,d.  The aggregate size increases in time as observed in Fig. 3c-
d consistent with shrinking GUV diameter from 18 to 11 m in 180 s.  Also note the clear 
presence of the green labeled Gag on the buds and the aggregate.  This observation that the buds 
stay attached to the GUV surface, i.e., do not detach and escape from the GUV, is consistent with 
the absence of host cell proteins, including ESCRT, in the experiment.  In HIV-1 replication, the 
ESCRT complex of the host is engaged by the p6 domain of the Gag affecting the scission of the 
buds from the plasma membrane [44-46,43,47,48].  
 
The bud formation on the inside surface of the GUV after the introduction of the Gag is 
consistent with the evolution of mini-vesicles. In immature HIV-1 the budding process is thought 
to be energetically driven by the self assembly of the CA domains of Gag into hexamers [16,14].  
The rigid rod like shape of the Gag induces membrane curvature. Membrane interaction with 
myristoylated MA domain provides the mechanical force driving membrane shape changes.   
Since the size resolution of confocal microscopy is only 0.5 m, one cannot say with certainty 
that these mini-vesicles correspond to virus like particles. All these observations indicate are that 
Gag proteins introduced into the solution outside the GUV bind to the outside lipid leaflet of the 
GUV. Gag multimerization then leads to membrane invagination towards the GUV center, 
resulting in the observed buds on the inside surface.  Based on lipid volume conservation of the 
original 33 m diameter GUV, the aggregate has to be composed of hollow mini-vesicles, as the 
amount of solid lipid forming the initial GUV is much less than the 10x10x5 m3 aggregate size 
that is observed.   
It is instructive to compare the similar budding phenomena that have been observed in 
other systems such as Shiga toxin (STxB) [49] and ESCRT  [43,50].  In the case of STxB, the 
invagination of tubules by the glycolipid binding B-subunit of bacterial STxB in GUV composed 
of DOPC, cholesterol and porcine Gb3 glycolipid was investigated [49]. The spontaneous 
clustering of the toxin on the GUV surface was imaged by confocal microscopy.   The clusters of 
STxB resulted in tubular invaginations on lowering of the membrane tension due to the GUV 
surface increase from BodipyFL-C5-HPC photo activation or by increasing the osmotic pressure 
of the bath [49].  The authors proposed the STxB-Gb3 cluster complex led to a negative 
curvature [49] similar to the case of aggregation of Gags observed in this paper.  In the case of 
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host cell proteins, such as ESCRT, interacting with GUV, the models project formation of 
microdomain clusters leading to an increase in the line tension along the domain boundaries 
resulting in buckling and formation of a bud when its exceeds a threshold level. The physical 
mechanism that leads to membrane budding with ESCRTs is presently not understood.  The 
ESCRT complexes observed on the neck of the bud form a scaffold with an optimum size 
necessary for scission.  These steps predict a large energy cost of 100 KBT necessary for the 
complete release of the minivesicles [50].   In the studies here, as host cell proteins are absent, 
the large energy costs for scission of the buds from the vesicle prevent their dissociation from the 
surface of the GUV.  
 
Gag interaction and rate kinetics with RNA containing GUV: 
The change in the GUV diameter as a function of time is shown in Fig. 4. Time t=0 
relates to the addition of Gag corresponding to a 10 nM Gag concentration into the GUV test 
cell.  The solid line is a smooth fit to the data and meant as an aid to the eye.  The change in the 
diameter is close to linear over the entire period of 240 s the GUV was studied at this Gag 
concentration.  The rate of change in the GUV diameter is -0.035 m/s.  Next the Gag 
concentration in the test cell was increased to 20 nM after 240 s, as indicated by the arrow in Fig. 
4.  The diameter undergoes a rapid change, probably due to the nonequilibrium Gag 
concentration caused by the injection of Gag.  As the Gag solution was pipetted in the vicinity of 
the GUV, the concentration was higher than 20 nM immediately after its introduction.  After 
equilibration, determined to be around 90 s after Gag addition, the rate of decrease in the GUV 
diameter in the linear region was found to be -0.067 m/s.  Thus an increase in the Gag 
concentration from 10 nM to 20 nM resulted in a rate of change of GUV diameter from 0.035 to 
0.067 m/s.  A higher Gag concentration is expected to promote multimerization [51] leading to 
increased budding.  The rate increase in vesicle formation along with the decrease of the 
diameter as a function of Gag concentration is consistent with enhanced vesicle budding.  
 
Effect of urea and rate kinetics with Gag containing GUV:    
We sought to clarify the role of urea in the Gag solution used to understand the interaction 
with RNA containing GUV above. Towards this end we incubated DyLight 488 labeled 
myristylated Gag (50nM) with DilC18 labeled GUV solution for an hour, and the GUVs were 
analyzed with a confocal microscope.  Similar to Fig. 1, images of the GUV had uniform bright 
green Gag punctae on the bilayer membrane as shown in Fig. 5a and no budding or local 
distortions of the GUV surface could be observed.   Next five l of 6 M urea were added to the 
two ml test cell (15 mM urea final concentration) with the Gag containing GUVs. The GUVs 
rapidly shrunk and disintegrated into mini-vesicles within 10 s of addition of the urea. The 
sequence of time events for one such GUV is shown in Fig. 5.  In contrast to the case with the 
presence of RNA (Fig. 3), no buds were observed on the interior wall of the GUV.  Only 
subvesicles were observed attached to the exterior GUV wall after urea addition as shown in Fig. 
5c. Urea is a well known chaotropic agent used for the solubilization of proteins. Its role in the 
activation of Gag bound to the GUV membrane might be due to conformational changes 
introduced by the urea interaction.   The corresponding change in the GUV diameter as a 
function of time is shown in Fig. 6.  The rate of change of diameter was 0.6 m/s.  This is 20 
times faster than that observed with RNA containing GUVs.  
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As mentioned in Methods and Materials, various controls were done. In particular, 
unmyristoylated Gag P55 and the capsid domain Gag P24 were prepared in the same manner as 
the myristoylated Gag P55 with urea above and the experiments repeated. The GUVs remained 
unaltered and no budding phenomena was observed.  N terminal myristoylation of Gag P55 has 
been shown necessary for binding to lipid membranes and formation of virus like particles [31-
33].  Thus the absence of myristoyl group in the controls prevents their insertion into the GUV 
membrane. The action of urea of the same concentration as used above on the GUVs was also 
studied and found to have no effect.     
        The rates of HIV-1 assembly and release in HeLa cells have been studied with Total 
Internal Reflection Fluorescence Microscopy (TIRFM) [22,21].  Atomic force microscopy 
studies of retroviral budding were done on murine leukemia virus (MLV) [23].  In TIRFM the 
fluorescence saturation time for Gag-GFP puncta was used as a marker and found to be 5-9 mins 
(exponential time constant found to be 233 s  [22]).  The time taken for a rapid increase in 
velocity of these fluorescence units which was attributed to the virion release was found to be 
around 25 min [22].  Note that only the formation of the Gag puncta could be detected by 
TIRFM.  The budding of the virus like particles can only be inferred.  The budding time scales 
for MLV in mouse fibroblast cells were found to be around 45 mins [23].  These values are not 
directly comparable to the experiments reported on the GUV, as Gag and viral RNA have to be 
expressed and transported across the cells. Diffusion rates alone in the cytoplasm are factor of 10 
smaller in cells and thus the virus assembly rates would be correspondingly less.  Thus the time 
scales for budding observed in GUVs are probably consistent with those observed in vivo after 
accounting for the diffusion rates.   
Conclusion 
We used a highly simplified minimalist experimental system of a GUV for the cell-free in 
vitro study of HIV-1 particle assembly mechanism and kinetics.  Real time interaction of Gag, 
RNA and lipid was measured using confocal microscopy.   Gag was found to lead to resolution 
limited punctae on the GUV lipid membranes. Even though, due to the optical resolution limit, 
the curvature of the domains cannot be observed, based on the physical arguments, we conclude 
that Gag aggregates form domains that are curved. This is based on the fact that flat domains 
would diffuse and coalesce to form even larger aggregates. However, in this system Gag punctae 
repel each other and their sizes remain finite. The size of a puncta depends on the spontaneous 
curvature of Gag proteins, the membrane bending rigidity and tension, and unfavorable energetic 
costs at the domain boundary.  
We also found that RNA interacting with GUV caused lipid density inhomogeneities on 
the GUV surface, which might be precursors to raft formation.  The introduction of Gag in urea 
to a GUV solution containing RNA led to the budding of mini-vesicles on the inside surface of 
the GUV.  The GUV diameter decreased due to bud formation. The corresponding rate of 
decrease of the GUV diameter was found to be linear in time. The bud formation and the 
decrease in GUV size were found to be proportional to the Gag concentration.  In the absence of 
RNA, the addition of urea to GUV membranes incubated with Gag also led to the formation of 
subvesicles. Controls using unmyristoylated Gag P55 with urea, the capsid domain Gag P24 and 
urea alone were found not to alter the GUVs.   In all cases, the GUV remained stable in the 
absence of myristoylated Gag P55 and urea.  The overall approach used here will allow for a 
systematic study of the dynamics and help classify the hierarchy of factors that impact the Gag 
10 
 
protein initiated assembly of retroviruses.  In future studies, we will explore the role of the 
different domains of Gag and their interplay with lipids and RNA using mutant Gag.  
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Figure Captions 
 
 
Figure 1: Green labeled HIV-I myristoylated Gag P55 punctae can be observed on PI(4,5) P2 
containing GUV lipid membranes.  The lipid membrane of the GUV is stained with 0.1 mol %  
of red fluorophore DilC18.  Gag P55 was incubated with the GUV for 1 h prior to imaging.  
 
Figure 2: Action of RNA on the GUV lipid membrane.  The midplane of a typical GUV (a) 
before and (b) after addition of yeast tRNA. The inhomogeneities in the fluorescence intensity 
caused by the addition of RNA probably correspond to density modifications in the bilayer lipid 
membrane. (c)  Image after addition of myristoylated Gag P55 to a 10 nM concentration to GUV 
in (b). Vesicle budding (arrow pointing to one) on the inside surface of the GUV can be 
observed.  
 
Figure 3: Action of Yeast tRNA and green labeled myristoylated Gag P55 on GUVs leading to 
mini vesicle formation and shrinkage.  The images (a)-(d) show the same GUV as a function of 
time in one minute intervals after Gag concentration reaches 20 nM in the test cell.   In (a) 
vesicle budding with green labeled Gag can be observed on the inside surface of the GUV.  From 
(a)-(d) the diameter of the GUV shrinks due to the budding. The budded vesicles appear to 
aggregate in one location shown by arrow.  
 
Figure 4: Interaction of myristoylated Gag P55 with RNA containing GUV.  The same GUV was 
used for both concentrations. The GUV diameter decreased as a function of time due to the 
budding of mini-vesicles on the inside surface.  After equilibration, the rate of decrease in the 
GUV diameter is linear in time and Gag concentration. Thus an increase in the Gag 
concentration from 10 nM to 20 nM resulted in a rate of change of GUV diameter from 0.035 to 
0.067 m/s. The solid line is a smooth fit to the data to be used as an aid to the eye.  
 
Figure 5: Change in GUV on addition of five l of 6 M urea to the two ml test cell with 
myristoylated Gag P55 containing GUVs. The GUVs rapidly shrunk and disintegrated into mini-
vesicles within 10 s of addition of the urea.   
 
Figure 6: Interaction of urea with myristoylated Gag P55 containing GUV. The GUV diameter 
decreased as a function of time due to the formation of sub-vesicles exterior to the surface of the 
GUV.  After equilibration, the GUV diameter decreases almost linearly in time at the rate of 0.6 
m/s. The solid line is a smooth fit to the data to be used as an aid to the eye.  
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Results from controls performed are provided below. We studied the effect of: (i) Gag P24 the capsid 
domain of HIV-1 Gag P55 on GUVs, (ii) unmyristoylated Gag P55 in urea on GUVs and (iii) urea on 
GUVs.  All three did not affect the GUV and no bud formation was observed under the confocal 
microscope. In the case of Gag P24 and unmyristoylated Gag P55, which were both labelled green, no 
interaction with the lipid membrane of the GUV was observed.  
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Effect of Gag P24 the Capsid Domain of Gag P55 
 
The effect of Gag P24, the capsid domain of Gag P55, on GUVs was studied.  Here Gag P24 labelled 
with DyLight 488 in the same manner as myristoylated Gag P55 was added to the GUV containing test 
cell. The GUVs were observed in the confocal microscope (Fig. S1(a)) prior to the addition of Gag P24.  
Next, 10 l of the labeled Gag P24 were added to the test cell till the final concentration was 180 nM. As 
shown in Fig. S1(b), no changes in the GUVs were observed 41 minutes after the addition, even at this 
concentration, which is 10x of the concentration of myristoylated Gag P55 used.  No punctae on the GUV 
lipid membrane were observed. Thus the Gag P24 does not bind the lipid membrane of the GUVs. 
 
   
         
 
Figure S1: Effect of Gag P24, the capsid domain of Gag P55, on the GUV lipid membrane.  Gag P24 is 
labeled green and the lipid membrane is labeled red. The midplane of a typical GUV (a) before and (b) 41 
minutes after addition of green labeled Gag P24 in PBS.  Gag P24 is observed to not bind the GUV lipid 
membrane and also has no effect on its structure.  
 
  
 
Fig. S1 (a)  
 
Fig. S1 (b)  
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Effect of Unmyristoylated Gag P55 in urea on GUVs 
 
We studied the necessity of N terminal myristoylation of Gag P55 for binding to lipid membranes and the 
formation of virus like particles.  Unmyristoylated Gag is an excellent control to study the Gag mediated 
vesicle budding in GUVs.  The same steps as in the experiment reported with myristoylated Gag P55 in 
urea was repeated with unmyristoylated Gag P55.  Here green labelled 0.05 mg/ml unmyristoylated Gag 
P55 in urea was added in 5 l steps first and then 10l steps to the test cell containing GUV till the final 
concentration reached 28 nM Gag in 42 mM urea. The GUVs remained unchanged even 19 minutes after 
the addition when observed under the confocal microscope. Note that with myristoylated Gag P55 in urea 
the vesicle is completely transformed within a minute. The observations are shown in Fig. S2.  Even 
though the concentration of unmyristoylated Gag and urea reached nearly three times that of the case of 
myristoylated Gag no budding or decrease of the GUV surface area was observed. 
    
         
 
Figure S2: Effect of green labelled unmyristoylated Gag P55 in urea on the GUV lipid membrane. The 
midplane image of a typical GUV (a) before and (b) 19 mins after addition of green labelled 
unmyristoylated Gag P55 in urea.  The final concentration reached 28 nM Gag P55 in 42 mM urea.  No 
change in the GUVs is observed even though the concentration of Gag in urea is 3x times that of 
myristoylated Gag P55 in urea.    
 
 
Fig. S2 (a)  
 
 
Fig. S2 (b)  
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Effect of Urea on GUVs 
 
The effect of only urea on the GUVs was also studied.  0.6 M urea in PBS was added to the GUV 
containing test cell in 10 l steps till the concentration reached 15 mM (the same as used with 
myristoylated Gag P55), while they were observed under the confocal microscope. As shown in Fig. S3, 
again the GUVs remained unaltered and no vesicle budding on the GUV surface or decrease in the GUV 
diameter with time was observed.  No change in GUVs were observed even when the urea concentration 
was increased to 20 mM and observation time increased to 27 minutes.  The same was repeated for yeast 
RNA containing GUVs. Again no change due to the addition of urea was observed.  
 
 
   
         
        
Figure S3:  Effect of addition of urea to test cell containing GUVs. The midplane of a typical GUV under 
the confocal microscopy (a) before and (b) 27 minutes after addition of urea in PBS to a final 
concentration of 20 mM urea.  No change in the GUVs is observed with the addition of urea.  
 
 
 
Fig. S3 (a)  
 
 
 
Fig. S3 (b)  
 
 
 
